CISPLATIN-INDUCED OTOTOXICITY

Clinical trials for CISPLATIN-INDUCED OTOTOXICITY explained in plain language.

Never miss a new study

Get alerted when new CISPLATIN-INDUCED OTOTOXICITY trials appear

Sign up with your email to follow new studies for CISPLATIN-INDUCED OTOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Can a common supplement save hearing from chemo?

Prevention Recruiting now

This study is testing if a medication called N-acetylcysteine (NAC) can prevent hearing loss caused by a powerful chemotherapy drug called cisplatin. Researchers will compare hearing changes in 40 cancer patients who receive either NAC or a placebo while undergoing their cisplati…

Matched conditions: CISPLATIN-INDUCED OTOTOXICITY

Phase: PHASE2 • Sponsor: Siriraj Hospital • Aim: Prevention

Last updated Mar 24, 2026 12:02 UTC

CISPLATIN-INDUCED OTOTOXICITY

Get alerted when new CISPLATIN-INDUCED OTOTOXICITY trials appear

Can a common supplement save hearing from chemo?